Completed PHASE4 INTERVENTIONAL 1-arm NCT01922154

Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma

Sponsor: Siriraj Hospital

Interventions Trabeculectomy with mitomycinC intravitreal ranibizumab

Updated 6 times since 2017 Last updated: Jul 12, 2021 Started: Feb 28, 2009 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Glaucoma, Neovascular and is currently completed. Siriraj Hospital leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Sep 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Sep 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Siriraj Hospital

Data source: Siriraj Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand